Updated:
Health Investment Partners
Health Investment Partners investeert in innovatieve ondernemingen met duurzame ideeën voor de zorg. HIP investeert in veelbelovende, innovatieve bedrijven die...
Health Investment Partners
Health Investment Partners investeert in innovatieve ondernemingen met duurzame ideeën voor de zorg. HIP investeert in veelbelovende, innovatieve bedrijven die impact willen maken op gebied van preventie, efficiency en/of kwaliteit, met financiële middelen én hands-on begeleiding. Zo helpen zij ondernemingen naar de volgende fase en dragen bij aan het toegankelijk houden van de zorg.
General information
Firm type
Private Equity
Year founded
2016
Location
Region
Europe
Country
Netherlands
City
Amsterdam
Corporate office
Amsterdam, Netherlands
Principals
Marieke ’t Hart
Robert Schuman
Donar van den Berg
Mark Lenssen
Mohamed Boulahcen
Tom Ubaghs
Puck Konings
Sector focus
Frequently asked questions
Does Health Investment Partners invest only in the Netherlands, or across Europe?
The firm invests across Western and Northern Europe. While headquartered in Amsterdam—a major hub for health-tech investment—its mandate covers companies facing the challenge of scaling across fragmented European healthcare markets, not exclusively Dutch ones.
What stage of company does the firm typically target?
Health Investment Partners provides growth equity and expansion capital. It focuses on companies that have already achieved clinical validation or regulatory approval and now require specialized capital and operational expertise to scale commercially, spanning both early-stage and late-stage growth rounds.
Which healthcare sub-sectors does the firm focus on?
The firm concentrates on medical devices, digital health platforms, and healthcare services. These are sub-sectors where the path from regulatory approval to broad clinical adoption varies significantly by country, creating a role for an investor with deep domain-specific knowledge.
Who controls investment decisions at Health Investment Partners?
The firm does not publicly name its managing principals or investment committee members. Public records do not disclose the individuals responsible for final allocation decisions, a notable gap for institutional due diligence given the firm's specialized mandate.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on private equity firms?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: